BIOT-YG-I FIA Analyzer (Fluorescence Immunoassay Analyzer)

BIOT-YG-I is a fluorescence immunoassay system with single channel that measures the quantitative concentration of a targeted analyte in human blood and urine.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

ICE-100E Incubation Chamber

The incubation chamber is an auxiliary device for Biotime’s fluorescence immunoassay analyzer. The reaction temperature and time is critical for test results. The incubation chamber provides an optimized environment as well as automatic timers for test reactions to improve the reliability of test results.

FLI-600 FIA Analyzer

FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.

AFP Rapid Quantitative Test

Alpha-fetoprotein (AFP) is a protein produced primarily by the liver in a developing baby (fetus) and the portion of a developing embryo that is similar to the yolk cavity in bird eggs (yolk sac tissues). AFP levels are typically elevated when a baby is born and then decline rapidly.

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.

SARS-CoV-2 IgG/IgM Rapid Qualitative Test

The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay)

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the D-Dimer concentration in human sodium citrate anticoagulant-contained plasma (1:9) and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

ST2 Rapid Quantitative Test

ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.

Model	BIOT-YG-I
Principle	Fluorescent immunochromatography
Specimen	Whole Blood/ Serum/ Plasma/ Urine
Power adapter	AC220V, 3A, 50/60Hz
Interface	RS232, USB, Ethernet (Direct connection to LIS / HIS)
Information input	Touch screen, barcode reader
Data Storage	10,000 tests
	25℃±1℃
Size	225×220×113mm
Weight	2.5kg

Cardiac Markers	CTnI, MYO, CK-MB, NT-proBNP, D-Dimer, CTnI/MYO/CK-MB, CTnI/MYO/CK-MB/NT-proBNP/D-Dimer, HCY, h-FABP, BNP, ST2, LP-PLA2
Hormones Markers	β-HCG, PROG, E2, TES, FSH, LH, PRL, FSH/LH/PRL, AMH
Inflammation Markers	PCT, SAA, hsCRP+CRP, CRP/SAA, Total IgE, IL-6
Thyroid Markers	TSH, TT3, TT4, fT3, fT4
Diabetes and Renal Injury	HbA1c, MAU, Cys-C, NGAL
Tumor Markers	CEA, AFP, CEA/AFP, tPSA, fPSA, PGI, PGII, PGI/PGII
Health Check	25(OH)-D, Ferritin
Infectious Disease	HBsAg, HCV